MDNA Life Sciences Inc. (MDLS)

MDNA Life Sciences was planning to go public, but the IPO was withdrawn on Feb 21, 2025.

IPO Price Range

$5.00 - $6.00

Shares Offered

2,454,545

Deal Size

$13.50M

MDNA Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year Ending	Current	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Capitalization	52	-	-
Enterprise Value	68	-	-
Debt / Equity Ratio	-0.95	-0.95	-0.94
Debt / EBITDA Ratio	-11.27	-11.27	-4.30
Debt / FCF Ratio	-26.85	-26.85	-8.71
Net Debt / Equity Ratio	-0.89	-0.89	-0.94
Net Debt / EBITDA Ratio	-10.62	-10.62	-4.28
Net Debt / FCF Ratio	-25.31	-25.31	-8.68
Quick Ratio	0.06	0.06	0.03
Interest Coverage	-1.27	-1.27	-2.76
Return on Equity (ROE)	17.02%	17.02%	30.39%
Return on Assets (ROA)	-93.92%	-93.92%	-186.40%
Return on Capital Employed (ROCE)	12.93%	12.93%	251.06%